Related Experiment Video
Updated: May 16, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Delayed onset congenital hypothyroidism in a patient with DUOX2 mutations and maternal iodine excess
Toshihiko Kasahara1, Satoshi Narumi, Keisuke Okasora
1Department of Pediatrics, Higashitoyonaka Watanabe Hospital, Osaka, Japan.
Insights
Delayed-onset congenital hypothyroidism (CH) can occur due to genetic defects and environmental factors like excess iodine. This case highlights how these factors can impact newborn screening for CH.
Area of Science:
- Endocrinology
- Genetics
- Environmental Health
Background:
- Congenital hypothyroidism (CH) is a common endocrine disorder.
- Newborn screening diagnoses most CH cases, enabling early intervention and preventing intellectual disability.
- However, some CH cases present with delayed onset, evading newborn screening.
Observation:
- A patient presented with delayed-onset CH despite a negative newborn screening result.
- The patient had both a genetic defect (DUOX2 mutations) and in utero iodine excess (maternal seaweed consumption).
- Overt CH developed at 3 months, resolving by age 3 with thyroxine supplementation, indicating transient CH.
Findings:
- This case demonstrates a dual etiology for CH: a DUOX2 genetic mutation and environmental iodine excess.
- The combination of genetic predisposition and environmental factors masked CH during newborn screening.
- The patient experienced transient CH, emphasizing the phenotypic variability of genetic CH defects.
Implications:
- Environmental factors can significantly modify the phenotype of genetic CH, potentially leading to false-negative newborn screening results.
- This case underscores the importance of considering environmental exposures in diagnosing and managing CH.
- Further research is needed to understand the interplay between genetic and environmental factors in CH pathogenesis and screening accuracy.
Abstract:
Congenital hypothyroidism (CH), one of the most common congenital endocrine disorders, causes irreversible intellectual disability in untreated patients. Today, the vast majority of patients receive early diagnosis and treatment in the context of newborn screening for CH, and achieve satisfactory cognitive development. However, a subset of patients with delayed onset are undetectable by newborn screening, and miss benefit from early intervention. Here, we report on a delayed-onset CH patient that had two contributing factors in the pathogenesis of CH simultaneously, i.e., a genetic defect and iodine excess. The patient was exposed to excessive iodine in utero because her mother consumed massive amounts of seaweed during pregnancy. Surprisingly, the patient had a negative result in newborn screening, but developed overt CH at age 3 months. She received thyroxine supplementation until when normalization of the thyroid function was confirmed at age 3 years (i.e., transient CH). Mutation screening for DUOX2, a causative gene for transient CH, showed biallelic mutations (p.[E327X] + [H678R]). This report provides a new example of environmental modification of phenotypes of CH due to a genetic defect, which can potentially distort screening results.
Related Concept Videos
Hypothyroidism II: Pathophysiology
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Goiter
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves Disease II: Pathophysiology
